Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling

被引:48
作者
Craig, Morgan [1 ,2 ]
Jenner, Adrianne L. [1 ,2 ]
Namgung, Bumseok [3 ,4 ]
Lee, Luke P. [3 ,4 ]
Goldman, Aaron [3 ,4 ]
机构
[1] Univ Montreal, Dept Math & Stat, Montreal, PQ H3C 3J7, Canada
[2] St Justine Univ Hosp, Res Ctr, Montreal, PQ H3S 2G4, Canada
[3] Brigham & Womens Hosp, Div Engn Med, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02139 USA
基金
加拿大自然科学与工程研究理事会;
关键词
SINGLE-CELL ANALYSIS; GROWTH-FACTOR-BETA; PHOTODYNAMIC THERAPY; TUMOR HETEROGENEITY; ACQUIRED-RESISTANCE; CHECKPOINT BLOCKADE; MULTIDRUG-RESISTANCE; CISPLATIN RESISTANCE; PHOTOTHERMAL THERAPY; MOLECULAR EVOLUTION;
D O I
10.1021/acs.chemrev.0c00356
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug resistance has profoundly limited the success of cancer treatment, driving relapse, metastasis, and mortality. Nearly all anticancer drugs and even novel immunotherapies, which recalibrate the immune system for tumor recognition and destruction, have succumbed to resistance development. Engineers have emerged across mechanical, physical, chemical, mathematical, and biological disciplines to address the challenge of drug resistance using a combination of interdisciplinary tools and skill sets. This review explores the developing, complex, and under-recognized role of engineering in medicine to address the multitude of challenges in cancer drug resistance. Looking through the "lens" of intrinsic, extrinsic, and drug-induced resistance (also referred to as "tolerance"), we will discuss three specific areas where active innovation is driving novel treatment paradigms: (1) nanotechnology, which has revolutionized drug delivery in desmoplastic tissues, harnessing physiochemical characteristics to destroy tumors through photothermal therapy and rationally designed nanostructures to circumvent cancer immunotherapy failures, (2) bioengineered tumor models, which have benefitted from microfluidics and mechanical engineering, creating a paradigm shift in physiologically relevant environments to predict clinical refractoriness and enabling platforms for screening drug combinations to thwart resistance at the individual patient level, and (3) computational and mathematical modeling, which blends in silico simulations with molecular and evolutionary principles to map mutational patterns and model interactions between cells that promote resistance. On the basis that engineering in medicine has resulted in discoveries in resistance biology and successfully translated to clinical strategies that improve outcomes, we suggest the proliferation of multidisciplinary science that embraces engineering.
引用
收藏
页码:3352 / 3389
页数:38
相关论文
共 332 条
[61]   Photodynamic therapy for cancer [J].
Dolmans, DEJGJ ;
Fukumura, D ;
Jain, RK .
NATURE REVIEWS CANCER, 2003, 3 (05) :380-387
[62]   Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning [J].
Dorman, Stephanie N. ;
Baranoua, Katherina ;
Knoll, Joan H. M. ;
Urquhart, Brad L. ;
Mariani, Gabriella ;
Carcangiu, Maria Luisa ;
Rogan, Peter K. .
MOLECULAR ONCOLOGY, 2016, 10 (01) :85-100
[63]   Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development [J].
Doulatov, Sergei ;
Notta, Faiyaz ;
Eppert, Kolja ;
Nguyen, Linh T. ;
Ohashi, Pamela S. ;
Dick, John E. .
NATURE IMMUNOLOGY, 2010, 11 (07) :585-U52
[64]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[65]   Rapid prototyping of microfluidic systems in poly(dimethylsiloxane) [J].
Duffy, DC ;
McDonald, JC ;
Schueller, OJA ;
Whitesides, GM .
ANALYTICAL CHEMISTRY, 1998, 70 (23) :4974-4984
[66]   CURE OF HODGKINS DISEASE [J].
EASSON, EC ;
RUSSELL, MH .
BRITISH MEDICAL JOURNAL, 1963, (534) :1704-&
[67]   Tumors as Organs: Complex Tissues that Interface with the Entire Organism [J].
Egeblad, Mikala ;
Nakasone, Elizabeth S. ;
Werb, Zena .
DEVELOPMENTAL CELL, 2010, 18 (06) :884-901
[68]   Polymer-drug conjugate therapeutics: advances, insights and prospects [J].
Ekladious, Iriny ;
Colson, Yolanda L. ;
Grinstaff, Mark W. .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (04) :273-294
[69]   Stem cell gene expression programs influence clinical outcome in human leukemia [J].
Eppert, Kolja ;
Takenaka, Katsuto ;
Lechman, Eric R. ;
Waldron, Levi ;
Nilsson, Bjoern ;
van Galen, Peter ;
Metzeler, Klaus H. ;
Poeppl, Armando ;
Ling, Vicki ;
Beyene, Joseph ;
Canty, Angelo J. ;
Danska, Jayne S. ;
Bohlander, Stefan K. ;
Buske, Christian ;
Minden, Mark D. ;
Golub, Todd R. ;
Jurisica, Igor ;
Ebert, Benjamin L. ;
Dick, John E. .
NATURE MEDICINE, 2011, 17 (09) :1086-U91
[70]  
Ewens W. J., 2001, POPULATION GENETICS